NCT03494608

Brief Summary

This prospective single-center cohort study aims to identify the incidence of cognitive dysfunction after unruptured aneurysm operation and explore the influencing factors. The primary end point is the cognitive dysfunction at 6 months after operation.The features of cognitive function, mental status, neurological function recovery, and quality of life of patients with unruptured intracranial aneurysms at different time points would be analyzed.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 11, 2018

Completed
20 days until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

May 9, 2018

Status Verified

May 1, 2018

Enrollment Period

1.8 years

First QC Date

April 3, 2018

Last Update Submit

May 8, 2018

Conditions

Keywords

cognitive functionquality of lifeanxietydepressionneurological function

Outcome Measures

Primary Outcomes (1)

  • the Incidence of cognitive dysfunction at 6 months after operation

    The Montreal Cognitive Assessment Scale (MoCA) scale contains 8 cognitive domain,11 items and is suitable for assess cognitive function which including: Attention and concentration, executive function, memory, language, visual structure skills, abstract thinking, calculation and orientation.. 1 point for each correct answer. No points if they make any errors. The total score is 30 points. For those who have been educated for 12 years or less and the total score of MoCA is less than 30, one point is added to the total MoCA score. According to the results of MoCA assessment, Patients were divided into two groups: cognitive dysfunction group and cognitive function normal group. MoCA score ≥26 points suggested normal cognitive function (CN).

    the 6th month after operation of the patient inclusion in the study

Secondary Outcomes (4)

  • the difference in the percentage of patients with HAMA score ≥14 before operation and 6 months after operation

    before operation and the 6th month after operation of the patient inclusion in the study

  • the difference in the percentage of patients with HDMA score ≥14 before operation and 6 months after operation

    before operation and the 6th month after operation of the patient inclusion in the study

  • the tendency of mRS scores and the difference in the percentage of patients with mRS scores 0-3 and 4-6 points before operation, 3 months after operation, and 6 months after operation

    before operation ,the 3th month and the 6th month after operation of the patient inclusion in the study

  • the tendency of SF-36 scores before operation, 3 months after operation, and 6 months after operation

    before operation ,the 3th month and the 6th month after operation of the patient inclusion in the study

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

the patients with unruptured intracranial aneurysms who treated in neurosurgery at Xuanwu Hospital

You may qualify if:

  • At least one imaging (CTA / MRI / DSA) study to confirm unruptured intracranial aneurysms for the patients who would undergo surgical treatment for the first time.;
  • Patients who live independent with minimal care support, mRS score ≤3 points;
  • Age \> 14 years old;
  • Han ethnicity, Right handed, can complete the test;
  • Patient or family agrees to sign informed consent.

You may not qualify if:

  • Other cerebrovascular diseases,such as ischemic stroke, arteriovenous malformation, etc;
  • With an unexplained subarachnoid hemorrhage;
  • History of Neurological disease surgery;
  • Previous psychiatric and dementia history that cannot communicate with other people;
  • Patients who refused to follow up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Intracranial AneurysmAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular DiseasesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Jun Wang, Master

    Xuanwu Hospital, Beijing

    STUDY CHAIR

Central Study Contacts

Jun Wang, Master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief nurse of Neurosurgery Department, professor

Study Record Dates

First Submitted

April 3, 2018

First Posted

April 11, 2018

Study Start

May 1, 2018

Primary Completion

February 1, 2020

Study Completion

May 1, 2020

Last Updated

May 9, 2018

Record last verified: 2018-05